• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低结核病流行率国家结核病管理的成本决定因素

Cost determinants of tuberculosis management in a low-prevalence country.

作者信息

Bocchino M, Greco S, Rosati Y, Mattioli G, Marruchella A, De Mori P, Bibbolino C, Girardi E, Squarcione S, Saltini C

机构信息

Division of Respiratory Medicine, University of Rome Tor Vergata at the National Institute for Infectious Diseases L Spallanzani, Rome, Italy.

出版信息

Int J Tuberc Lung Dis. 2006 Feb;10(2):146-52.

PMID:16499252
Abstract

SETTING

Division of respiratory medicine in a specialised infectious disease hospital in Rome, Italy.

OBJECTIVE

Retrospective evaluation of tuberculosis (TB) care associated costs in an integrated in- and out-patient management programme.

DESIGN

Review of the medical records of 92 human immunodeficiency virus negative TB cases admitted between September 2000 and May 2003.

RESULTS

Length of in-hospital stay (45 +/- 35 days) was the major cost determinant, as hospitalisation accounted for almost 80% of the total costs of the case, with fixed bed-per-day charges amounting to 76% of hospital costs. Factors associated with higher costs were chest X-ray score, fever, sputum bacterial load and multidrug resistance (P < 0.05). Cure/treatment completion was achieved in 82% of patients entering the out-patient programme (63% of all cases). Homelessness, age and comorbidities were associated with unfavourable outcomes.

CONCLUSIONS

A closely followed hospital-centred protocol carried out in a high-resource setting may produce acceptable cure/completion treatment rates. As a too high fraction of resources invested in TB control goes toward hospital costs, out-patient treatment strategies should be implemented.

摘要

背景

意大利罗马一家专业传染病医院的呼吸内科。

目的

对综合门诊和住院管理项目中与结核病(TB)治疗相关的费用进行回顾性评估。

设计

回顾2000年9月至2003年5月期间收治的92例人类免疫缺陷病毒阴性结核病病例的病历。

结果

住院时间(45±35天)是主要的费用决定因素,因为住院费用几乎占病例总费用的80%,每日固定床位费用占住院费用的76%。与较高费用相关的因素有胸部X线评分、发热、痰菌载量和多重耐药性(P<0.05)。进入门诊项目的患者中82%(所有病例的63%)实现了治愈/完成治疗。无家可归、年龄和合并症与不良结局相关。

结论

在资源丰富的环境中实施密切跟踪的以医院为中心的方案可能会产生可接受的治愈/完成治疗率。由于投入结核病控制的资源中过高比例用于医院费用,应实施门诊治疗策略。

相似文献

1
Cost determinants of tuberculosis management in a low-prevalence country.低结核病流行率国家结核病管理的成本决定因素
Int J Tuberc Lung Dis. 2006 Feb;10(2):146-52.
2
Cost-effectiveness of different treatment strategies for tuberculosis in Egypt and Syria.埃及和叙利亚不同结核病治疗策略的成本效益
Int J Tuberc Lung Dis. 2002 Dec;6(12):1083-90.
3
Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa.南非耐多药结核病住院治疗费用。
Trop Med Int Health. 2013 Jan;18(1):109-16. doi: 10.1111/tmi.12018. Epub 2012 Nov 21.
4
Shifting the balance between in-patient and out-patient care for tuberculosis results in economic savings.调整结核病住院治疗和门诊治疗之间的平衡可节省费用。
Int J Tuberc Lung Dis. 2001 Mar;5(3):266-71.
5
Cost analysis of paediatric tuberculosis treatment in Japan.日本小儿结核病治疗的成本分析。
Int J Tuberc Lung Dis. 2003 Mar;7(3):254-7.
6
Costs incurred by patients with pulmonary tuberculosis in rural India.印度农村肺结核患者的费用支出。
Int J Tuberc Lung Dis. 2009 Oct;13(10):1281-7.
7
Cost of Gram-negative resistance.革兰氏阴性菌耐药的代价。
Crit Care Med. 2007 Jan;35(1):89-95. doi: 10.1097/01.CCM.0000251496.61520.75.
8
The cost of tuberculosis: utilization and estimated charges for the diagnosis and treatment of tuberculosis in a public health system.
Int J Tuberc Lung Dis. 1999 May;3(5):382-7.
9
[Preventive measures against tuberculosis in working facilities and companies].[工作场所和公司内的结核病预防措施]
Kekkaku. 2007 Mar;82(3):201-16.
10
Experiences of a community-based tuberculosis treatment programme in Namibia: a comparative cohort study.纳米比亚一项基于社区的结核病治疗项目的经验:一项比较队列研究。
Int J Nurs Stud. 2009 Mar;46(3):302-9. doi: 10.1016/j.ijnurstu.2008.09.013. Epub 2008 Nov 7.

引用本文的文献

1
A systematic review of economic evaluations of interventions to tackle tuberculosis in homeless people.一项针对解决无家可归者结核病干预措施的经济评估的系统评价。
Rev Panam Salud Publica. 2018 Mar 30;42:e40. doi: 10.26633/RPSP.2018.40. eCollection 2018.
2
Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy.贝达喹啉在意大利耐多药和广泛耐药结核病治疗中的成本效益
J Mark Access Health Policy. 2017 Feb 17;5(1):1283105. doi: 10.1080/20016689.2017.1283105. eCollection 2017.
3
Predictors of hospitalization of tuberculosis patients in Montreal, Canada: a retrospective cohort study.
加拿大蒙特利尔市结核病患者住院治疗的预测因素:一项回顾性队列研究。
BMC Infect Dis. 2016 Nov 15;16(1):679. doi: 10.1186/s12879-016-1997-x.
4
Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.结核病治疗对医疗服务机构和患者的成本:一项系统文献综述
Pharmacoeconomics. 2015 Sep;33(9):939-55. doi: 10.1007/s40273-015-0279-6.
5
Trends in duration of hospitalization for patients with tuberculosis in Montreal, Canada from 1993 to 2007.1993 年至 2007 年加拿大蒙特利尔市肺结核患者住院时间趋势。
Can J Public Health. 2011 Mar-Apr;102(2):108-11. doi: 10.1007/BF03404157.